Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients. - Université de Montpellier
Article Dans Une Revue Journal of Invasive Cardiology Année : 2018

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.

Résumé

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before percutaneous coronary intervention (PCI) in elective and non-ST segment elevation myocardial infarction (NSTEMI) patients. The aim of this study was to assess outcomes after performing PCI immediately after coronary angiography with an exclusive "on-the-table" P2Y12 inhibitor loading dose, by evaluating ischemic and bleeding complications in unselected patients.
Fichier non déposé

Dates et versions

hal-01843141 , version 1 (18-07-2018)

Identifiants

  • HAL Id : hal-01843141 , version 1
  • PUBMED : 30012889

Citer

Benoit Lattuca, David Belardi, Christophe Demattei, Laurent Schmutz, Luc Cornillet, et al.. Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.. Journal of Invasive Cardiology, 2018. ⟨hal-01843141⟩
289 Consultations
0 Téléchargements

Altmetric

Partager

More